RecruitingPhase 3NCT06810167

Assessing Tenapanor as a Treatment of CF-related Constipation.

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Massachusetts General Hospital
Principal Investigator
Christoher D Velez, MD
Massachusetts General Hospital
Intervention
Tenapanor(drug)
Enrollment
25 enrolled
Eligibility
18-75 years · All sexes
Timeline
2025 – 2027

Study locations (1)

Collaborators

Ardelyx

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06810167 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis →

← Back to all trials